IGC Reports Financial Results for September 30, 2020 Quarter and Start of Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients November 23, 2020 Read More »
IGC Commences Phase 1 of Cannabinoid Clinical Trial for Alzheimer’s Patients November 23, 2020 Read More »
IGC Reports Financial Results for June 30, 2020 Quarter and Prepares for Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients August 20, 2020 Read More »
IGC Announces Proposed Settlement of 3 Derivative Lawsuits & Provides Notice to Shareholders May 8, 2020 Read More »
